SCHEMBL18090491

SCHEMBL18090491

Cc1ccc(N(c2ccc(C)cc2)c2cc(Br)cc(N(c3ccccc3)c3ccccc3)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
CYP2C19 P33261 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
APP P05067 1/20 0.37
TSHR P16473 2/20 0.37
LMNA P02545 1/20 0.37
ALOX12 P18054 1/20 0.37
ACHE P22303 1/20 0.37
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
CRHBP P24387 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12003824 1.00 ALDH1A1 (0.42) ALDH1A1L3MBTL1CYP2C19TDP1KDM4E
SCHEMBL18090495 0.93 ALDH1A1 (0.41) ALDH1A1L3MBTL1CYP2C19TDP1KDM4E
SCHEMBL12006260 0.92 ALDH1A1 (0.46) ALDH1A1CYP2C19TDP1KDM4ECYP1A2
SCHEMBL12240221 0.90 ALDH1A1 (0.50) ALDH1A1L3MBTL1CYP2C19TDP1KDM4E
SCHEMBL13990422 0.90 ALDH1A1 (0.50) ALDH1A1L3MBTL1CYP2C19TDP1KDM4E
SCHEMBL15015459 0.88 ALDH1A1 (0.46) ALDH1A1CYP2C19TDP1KDM4ECYP1A2
SCHEMBL12003842 0.88 ALDH1A1 (0.46) ALDH1A1L3MBTL1CYP2C19TDP1KDM4E
SCHEMBL19738280 0.86 ALDH1A1 (0.40) ALDH1A1L3MBTL1CYP2C19TDP1KDM4E
SCHEMBL19414604 0.86 ALDH1A1 (0.56) ALDH1A1L3MBTL1CYP2C19TDP1KDM4E
SCHEMBL516760 0.86 ALDH1A1 (0.56) ALDH1A1L3MBTL1CYP2C19TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180072695-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-03-15 US disclosed
WO-2016148425-A2 COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC APPARATUS FOR SAME 덕산네오룩스 주식회사 2016-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180072695-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, LEF1 ALDH1A1 493/4885L3MBTL1 1020/4885CYP2C19 681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.